用于治疗决策的患者简介数据:作为补充C型肝炎临床指南的有价值吗?
Sylvia M Brakenhoff1, Thymen Theijse2, Peter van Wijngaarden3
1Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands. s.brakenhoff@erasmusmc.nl.
BMC medical informatics and decision making
|August 13, 2024
概括
一个新的指南补充,TherapySelector,改善了C型肝炎的治疗选择,最大限度地减少了不良影响和成本. 它的使用随着时间的推移而增加,显示出优化复杂疾病患者护理的潜力.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 临床决策支持系统 临床决策支持系统
- 基于证据的医学 基于证据的医学
背景情况:
- 目前针对C型肝炎 (HCV) 治疗的临床指导方针往往过时,缺乏针对患者的具体重点.
- 一个新的指南补充,TherapySelector (TS),利用每月更新的数据和患者个人资料来增强治疗建议.
研究的目的:
- 评估TherapySelector (TS) 作为C型肝炎 (HCV) 治疗指南附加剂的疗效.
- 评估TS对患者治疗选择,治愈率,副作用和治疗持续时间的影响.
主要方法:
- 分析了2015年至2020年间567名患者的国际队列,这些患者在2015年至2020年期间用直接作用抗病毒药物治疗HCV.
- 衡量的主要结局是接受HCV TS推的两种首选治疗方案之一的患者比例.
主要成果:
- 接受首选TS治疗方案的患者比例显著增加,从2015年的27%增加到2020年的60% (p < 0.001).
- 显著的比例的患者接受了较长的治疗时间 (高达34%) 和/或利巴维林 (高达14%) 与TS偏好不一致.
- 与实际治疗相比,坚持第一个首选的TS选择导致预期治愈率 (1-6%) 的最小增加.
结论:
- 像TherapySelector这样的指南附加组件可以优化型肝炎治疗中的医疗决策,潜在地减少不良影响和成本.
- 这种工具的应用可能特别有利于具有低于最佳治愈率,高治疗成本或显著不良影响的疾病,其中个性化治疗至关重要.
相关概念视频
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Chronic Pancreatitis II: Collaborative Care
79
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
79
Drug Administration and Therapy Phases: Overview
418
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
418


